Markets:

Overview

News

Currencies

International

Treasuries

TransMedics Group, Inc. - Common Stock (NQ:TMDX)

131.98 +5.70 (+4.51%)

Streaming Delayed Price Updated: 10:38 AM EST, Jan 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about TransMedics Group, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

TransMedics Group Inc. (NASDAQ:TMDX) Combines High-Growth Momentum with Bullish Technical Setup ↗

Today 5:51 EST

Via Chartmill

6 Multibagger Stocks to Buy Before They Explode in 2026 ↗

December 29, 2025

With great returns comes added volatility.

Via The Motley Fool

Here Are My Top 2 No-Brainer Growth Stocks to Buy Now ↗

December 27, 2025

These businesses are innovators in their respective industries.

Via The Motley Fool

Topics Artificial Intelligence Economy

Nasdaq Bears Dig In: Short Interest Hits Record 18.38 Billion Shares Amid Valuation Anxiety

December 24, 2025

As the final trading days of 2025 approach, the Nasdaq has reached a staggering milestone that has both bulls and bears on edge. According to the latest settlement data released on December 15, 2025,...

Via MarketMinute

Topics Artificial Intelligence Economy Stocks

Earnings Scheduled For October 29, 2025 ↗

October 29, 2025

Via Benzinga

A Peek at TransMedics Gr's Future Earnings ↗

October 28, 2025

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX) Emerges as a Prime GARP Candidate ↗

December 13, 2025

TransMedics (TMDX) exemplifies Growth at a Reasonable Price (GARP) with strong revenue growth, solid industry valuation, and improving profitability in medical tech.

Via Chartmill

2 Under-the-Radar Stocks That Have Soared This Year ↗

December 09, 2025

These companies are worth your attention.

Via The Motley Fool

TransMedics Director Sells 4,142 Shares as Wall Street Maintains Buy Ratings: Is the Stock Still a Buy? ↗

December 08, 2025

A TransMedics executive trimmed his position by $540,300.

Via The Motley Fool

Topics Regulatory Compliance

3 Top Stocks to Buy in December ↗

December 01, 2025

These stocks deserve a spot on investors' shopping lists this holiday season.

Via The Motley Fool

1 Growth Stock I'm Thankful for -- and the Unstoppable Stock I'm Buying Using the Lessons It Taught Me ↗

November 24, 2025

Without learning from my worst investing decision, I would have missed out on many of my best long-term investments.

Via The Motley Fool

Dycom Industries, BellRing Brands, Lumentum And Other Big Stocks Moving Higher On Wednesday ↗

November 19, 2025

Via Benzinga

4 Growth Stocks to Buy After the Recent Crash ↗

November 18, 2025

All four trade at reasonable valuations.

Via The Motley Fool

Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks ↗

November 13, 2025

Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten.

Via Benzinga

2 Strong Healthcare Stock Picks for Growth Investors ↗

November 13, 2025

If you're a growth-oriented stock buyer, there are plenty of options in the healthcare space.

Via The Motley Fool

TransMedics Group Inc (NASDAQ:TMDX): An Affordable Growth Stock for GARP Investors ↗

November 04, 2025

TransMedics Group (TMDX) is a GARP stock with strong revenue & EPS growth, reasonable valuation vs. peers, and a solid financial position.

Via Chartmill

TransMedics Group Inc (NASDAQ:TMDX) Passes Rigorous Growth Stock Screen ↗

October 30, 2025

Discover how TransMedics Group (TMDX) exemplifies a powerful growth investing strategy with explosive sales, earnings growth, and soaring profitability.

Via Chartmill

Retail Traders Swarm TransMedics After Q3 Print— Retail Bulls Call It A ‘Hardcore Dip Buy’ ↗

October 30, 2025

TransMedics shares fell 9% in after-hours trading after its third-quarter results showed strong year-over-year growth but a sequential slowdown and margin pressure.

Via Stocktwits

TransMedics (TMDX) Q3 2025 Earnings Transcript ↗

October 29, 2025

TransMedics (TMDX) Q3 2025 Earnings Transcript

Via The Motley Fool

Topics Earnings

TransMedics Group Inc (NASDAQ:TMDX) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss ↗

October 29, 2025

TransMedics (TMDX) Q3 2025 results show a mixed picture: EPS of $0.66 beat estimates by 84.6%, but revenue of $143.82M slightly missed forecasts.

Via Chartmill

4 Stocks to Load Up on Before Earnings ↗

October 26, 2025

It might be worth buying these companies before the market notices they are undervalued.

Via The Motley Fool

This CME Group Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

October 23, 2025

Via Benzinga

Here's How Much $1000 Invested In TransMedics Group 5 Years Ago Would Be Worth Today ↗

October 13, 2025

Via Benzinga

Is TransMedics Group Inc Gaining or Losing Market Support? ↗

October 13, 2025

Via Benzinga

4 Analysts Have This To Say About TransMedics Group ↗

October 13, 2025

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX): A GARP Investment with Strong Growth and Fair Valuation ↗

October 10, 2025

TransMedics (TMDX) is a top GARP stock with explosive revenue & earnings growth, strong profitability, and a reasonable valuation relative to its industry peers.

Via Chartmill

2 Outstanding Healthcare Stocks to Buy and Hold for a Decade ↗

October 08, 2025

These stocks are crushing the market this year, and there is likely plenty of upside ahead.

Via The Motley Fool

If You Invested $100 In TransMedics Group Stock 5 Years Ago, You Would Have This Much Today ↗

September 25, 2025

TransMedics Group (NASDAQ: TMDX) has outperformed the market over the past 5 years by 37.76% on an annualized basis producing an average annual return of 52.39%. Currently, TransMedics Group has a...

Via Benzinga

TransMedics Group Inc (NASDAQ:TMDX) Emerges as a Top Affordable Growth Stock ↗

September 18, 2025

TransMedics (TMDX) is a top affordable growth stock with strong revenue & EPS growth, solid financial health, and a reasonable valuation in the organ transplant tech sector.

Via Chartmill

The Analyst Verdict: TransMedics Group In The Eyes Of 4 Experts ↗

September 16, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.